一年成本不及一人工资!诺和诺德已将AI引入药物监管文件的起草工作,并取得显著成效。据媒体报道,去年,丹麦制药巨头诺和诺德开始测试Anthropic的Claude 3.5 Sonnet模型,负责监督AI使用的战略总监Waheed Jowiya发现错误数量显著下降。目前,诺和诺德已经开始使用Claude起草临床研究报告,每份可长达数百页。多年来,诺和诺德一直在测试包括OpenAI的ChatGPT和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.